Reinhard Voll

Principal Investigator
(Alumni)

Center for Medicine
Department of Rheumatology and Clinical Immunology & Center for Chronic Immunodeficiency
Medical Center – University of Freiburg

Breisacher Str. 115
79106 Freiburg i. Brsg.

Current position

W3 Professor, Director, Department of Rheumatology and Clinical Immunology,

Center for Medicine, Medical Center – University of Freiburg

Academic training

1984 – 1991 Study of Medicine in Erlangen

Scientific qualifications

2004 Habilitation in Internal Medicine, University of Erlangen-Nürnberg (Mentor: Prof. Dr. med. Drs. h.c. Joachim R. Kalden)
1993 Dissertation in Medicine, University of Erlangen-Nürnberg (Supervisor: Prof. Dr. med. Bernhard Fleckenstein)

Postgraduate Positions

since 2010 W3 Professor, Director, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg
2003 – 2010 Consultant and Group leader, Department of Rheumatology and Clinical Immunology, University Hospital Erlangen
1999 – 2003 Resident, Department of Internal Medicine 3 (Rheumatology and Clinical Immunology, Hematology, Oncology),
University Hospital Erlangen
1996 – 1998 Postdoctorate (DFG), Laboratory of Dr. Sankar Ghosh, Section of Immunobiology, Yale University School of Medicine, New Haven, USA
1995 – 1996 Resident, Department of Rheumatology and Clinical Immunology, Hematology, Oncology, University Hospital Erlangen
1993 – 1994 Postdoctorate, Max-Planck-Society, Clinical Research Units for Rheumatology, University Hospital Erlangen
1991 – 1992 Assistant physician, Department of Rheumatology and Clinical Immunology, Hematology, Oncology, University Hospital Erlangen

Miscellaneous (Honors, Awards)

2009 Prize for Clinical Research, Glaxo-SmithKline Foundation
2004 Fellow of the ACR-EULAR Exchange Program

Publications based on CRC1160 funding

Rizzi, M., R. Lorenzetti, K. Fischer, J. Staniek, I. Janowska, A. Troilo, V. Strohmeier, M. Erlacher, M. Kunze, B. Bannert, D. Kyburz, E. Voll, N. Venhoff, and J. Thiel. 2017. Impact of tofacitinib treatment on human B-cells in vitro and in vivo. J Autoimmun 77: 55-66.

Herrtwich L, Nanda I, Evangelou K, Nikolova T, Horn V, Sagar, Erny D, Stefanowski J, Rogell L, Klein C, Gharun K, Follo M, Seidl M, Kremer B, Münke N, Senges J, Fliegauf M, Aschman T, Pfeifer D, Sarrazin S, Sieweke MH, Wagner D, Dierks C, Haaf T, Ness T, Zaiss MM, Voll RE, Deshmukh SD, Prinz M, Goldmann T, Hölscher C, Hauser AE, Lopez-Contreras AJ, Grün D, Gorgoulis V, Diefenbach A, Henneke P, Triantafyllopoulou A. 2016. DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas. Cell. 167(5):1264-1280.